1. Home
  2. VYGR vs ISTR Comparison

VYGR vs ISTR Comparison

Compare VYGR & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • ISTR
  • Stock Information
  • Founded
  • VYGR 2013
  • ISTR 2006
  • Country
  • VYGR United States
  • ISTR United States
  • Employees
  • VYGR N/A
  • ISTR N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • ISTR Major Banks
  • Sector
  • VYGR Health Care
  • ISTR Finance
  • Exchange
  • VYGR Nasdaq
  • ISTR Nasdaq
  • Market Cap
  • VYGR 172.6M
  • ISTR 189.6M
  • IPO Year
  • VYGR 2015
  • ISTR 2014
  • Fundamental
  • Price
  • VYGR $3.19
  • ISTR $21.70
  • Analyst Decision
  • VYGR Strong Buy
  • ISTR Buy
  • Analyst Count
  • VYGR 8
  • ISTR 1
  • Target Price
  • VYGR $14.33
  • ISTR $27.00
  • AVG Volume (30 Days)
  • VYGR 647.7K
  • ISTR 32.3K
  • Earning Date
  • VYGR 08-12-2025
  • ISTR 07-21-2025
  • Dividend Yield
  • VYGR N/A
  • ISTR 2.02%
  • EPS Growth
  • VYGR N/A
  • ISTR 46.28
  • EPS
  • VYGR N/A
  • ISTR 2.24
  • Revenue
  • VYGR $66,958,000.00
  • ISTR $90,347,000.00
  • Revenue This Year
  • VYGR N/A
  • ISTR $10.96
  • Revenue Next Year
  • VYGR $78.89
  • ISTR $61.82
  • P/E Ratio
  • VYGR N/A
  • ISTR $9.75
  • Revenue Growth
  • VYGR N/A
  • ISTR 12.03
  • 52 Week Low
  • VYGR $2.65
  • ISTR $15.39
  • 52 Week High
  • VYGR $9.55
  • ISTR $24.81
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 48.20
  • ISTR 54.13
  • Support Level
  • VYGR $3.15
  • ISTR $21.49
  • Resistance Level
  • VYGR $3.79
  • ISTR $22.70
  • Average True Range (ATR)
  • VYGR 0.21
  • ISTR 0.52
  • MACD
  • VYGR 0.00
  • ISTR -0.15
  • Stochastic Oscillator
  • VYGR 16.67
  • ISTR 17.70

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

Share on Social Networks: